Gaslightwala Abizer — SEC Form 4 filings
SEC reporting owner CIK 2049375. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-12-27 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 4 filings — 52,146 shares, $56,660 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: purchase of 15,000 shares @ $1.20 ($18,000) in Akari Therapeutics Plc, filed 2025-06-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | CEO, Director | 15 | 7 legs · 52,146 sh · $56,660 | — | 19 |
Form 4 filings — Gaslightwala Abizer
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 15,563 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Akari Therapeutics Plc (AKTX) | Purchase (P): 309,328 (derivative) · Purchase (P): 309,328 (derivative) @ $0.40 · Purchase (P): 773,323 (derivative) · Purchase (P): 773,323 (derivative) @ $0.40 | EDGAR |
| 2025-08-29 | 4 | Akari Therapeutics Plc (AKTX) | Purchase (P): 10,000 @ $0.94 · Purchase (P): 8,000 @ $0.93 · Purchase (P): 3,000 @ $0.90 | EDGAR |
| 2025-06-25 | 4 | Akari Therapeutics Plc (AKTX) | Purchase (P): 943 @ $1.15 · Purchase (P): 5,203 @ $1.16 | EDGAR |
| 2025-06-24 | 4 | Akari Therapeutics Plc (AKTX) | Purchase (P): 10,000 @ $1.20 | EDGAR |
| 2025-06-20 | 4 | Akari Therapeutics Plc (AKTX) | Purchase (P): 15,000 @ $1.20 | EDGAR |
| 2025-06-16 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 20,000 @ $1.23 · Grant/award (A): 25,000 @ $1.19 | EDGAR |
| 2025-06-12 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 20,000 @ $1.27 | EDGAR |
| 2025-03-24 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 1,100,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 133,928 @ $1.12 · Grant/award (A): 133,928 (derivative) @ $1.12 · Grant/award (A): 133,928 (derivative) @ $1.12 | EDGAR |
| 2025-02-07 | 4/A | Akari Therapeutics Plc (AKTX) | Grant/award (A): 11,640 @ $1.22 | EDGAR |
| 2025-01-13 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 11,439 @ $1.22 | EDGAR |
| 2025-01-07 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 1,720,000 @ $0.00 | EDGAR |
| 2024-12-30 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 40,000,000 @ $0.00 | EDGAR |
| 2024-12-27 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 30,000,000 @ $0.00 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2049375 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →